No IP Info For Protonix Antitrust Plaintiffs: Judge

Law360, New York (June 2, 2008, 12:00 AM EDT) -- Would-be class action plaintiffs in a case claiming Altana Pharma AG and Wyeth fraudulently obtained a patent for ulcer drug Protonix in order to maintain a monopoly have lost their bid to obtain discovery from another case challenging the patent's validity.

U.S. District Judge Jose L. Linares of the District of New Jersey ruled on Friday that drug wholesalers Dik Drug Co. and King Drug Company of Florence were not entitled to materials produced in patent litigation between Altana and Teva Pharmaceuticals USA Inc.

Antitrust cases...
To view the full article, register now.